회사 개요
Clover Health Investments, Corp. is a healthcare entity that specializes in delivering Medicare Advantage plans across the United States, utilizing preferred provider organization and health maintenance organization models for Medicare-eligible individuals. The company also operates Clover Assistant, a specialized software platform designed to assist physicians in detecting and managing patient needs. This enterprise operates within the broader Healthcare sector, specifically targeting the Healthcare Plans industry, which implies a focus on insurance administration and managed care services rather than direct pharmaceutical manufacturing or medical device production. The company currently holds a market capitalization of $1.00B and generates annual revenue of $1.92B while employing a workforce of 724 individuals. These valuation and revenue figures suggest that Clover Health occupies a significant niche within the Medicare Advantage landscape, indicating a substantial operational footprint despite the relatively modest employee count relative to its revenue scale.
재무 건전성
Clover Health Investments, Corp. reported revenue of $1.92B over the trailing twelve months, yet it recorded a net income of $-85,549,000 and an EBITDA of $-85,343,000 for the same period. The substantial disparity between the positive revenue of $1.92B and the negative net income reveals a cost structure where operational expenses and losses significantly outweigh the gross profits generated from sales. The company's free cash flow stands at $-35,821,624, which indicates a current lack of financial flexibility as the business is burning cash rather than generating liquidity from its core operations. Regarding profitability efficiency, the gross margin is 18.5%, while the operating margin is -10.1% and the profit margin is -4.4%, showing that the company struggles to convert revenue into operating profit and overall net earnings. On the balance sheet, the company holds cash of $120.26M against zero debt, resulting in a debt-to-equity ratio that is N/A due to the absence of debt. This capital structure suggests a highly conservative stance regarding leverage, as the firm carries no interest-bearing obligations to service. The current ratio is 1.47, indicating that the company possesses sufficient current assets to cover its short-term liabilities with a margin of safety above one. Furthermore, the return on equity is -26.3% and the return on assets is -9.5%, metrics that reveal that management has not yet been effective in generating returns on the capital invested or the assets utilized, resulting in value erosion rather than accretion.
밸류에이션 평가
The trailing twelve-month P/E ratio is listed as N/A due to the lack of earnings, whereas the forward P/E is 21.22, implying that the market prices the stock based on anticipated future profitability rather than historical performance. The price-to-book ratio stands at 3.21, suggesting that the market values the company at a significant premium over its net asset book value, likely reflecting confidence in future intangible assets or growth potential despite current losses. Alternative valuation metrics such as the price-to-sales ratio of 0.52 and an EV/EBITDA of -10.33 provide perspective, with the negative EV/EBITDA highlighting the company's unprofitable status and reliance on future cash generation to justify its current equity price. The stock has exhibited significant price volatility over the last year, trading between a 52-week high of $3.92 and a 52-week low of $1.58. Based on the provided range, the current trading position sits below the 52-week high but above the 52-week low, indicating ongoing price discovery within a wide trading band. The beta of 2.25 signifies that the stock's price volatility is more than double that of the broader market, meaning it experiences amplified swings during periods of market turbulence.
Growth & Income
Clover Health Investments, Corp. achieved a revenue growth rate of 44.7% year-over-year, while the earnings growth rate is N/A due to the company's continued unprofitability. Because the earnings are negative, the traditional metric of earnings growth cannot be calculated, yet the rapid revenue expansion suggests a scaling business model that is prioritizing market share acquisition over immediate profitability. As a non-dividend payer, the company does not distribute a dividend yield or utilize a payout ratio, which means all available cash flow is theoretically retained for operational reinvestment or balance sheet strengthening rather than shareholder income distributions. The overall growth and income profile characterizes Clover Health as a high-risk, high-growth venture that currently sacrifices current income generation to fuel rapid top-line expansion in the competitive Medicare Advantage sector.